Flibanserin a medication we’ve been following for more than 5 years, was finally approved by the FDA today.
Touted as the women’s Viagra, Flibanserin has the potential for healthy world wide sales in women who have “lost that loving feeling”:
“The review of flibanserin … represents a critical milestone for the millions of American women and couples who live with the distress of this life-impacting condition without a single approved medical treatment today,” Cindy Whitehead, Sprout’s CEO, said in a statement before the hearing began.
Because we are not here to debate the ethical questions regarding sexual dysfunction, we want to give you the straight science as we understand it.
First of all, enhancing a women’s libido is incredibly difficult to measure. Cindy Whitehead again sums it up best regarding women and desire:
“Sex is complex,”
“We bring our religion, how we were raised, and what’s going in our lives into the bedroom. But men and women alike bring biology into the bedroom.”
According to the most recent medical data, about 10% of pre-menopausal women suffer from Hypoactive Sexual Desire Disorder or HSDD.
People with HSDD are uninterested in sex regardless of mood or occasion, capped off with a heavy dose of distress and anxiety over doing the deed. Most importantly, their problem exists in the absence of any other notable culprits — psychiatric problems, for example, or drug side effects, or an inattentive partner.
When Monica and I think of all of our married couple friends who complain about their lack of sexual intimacy with one another, we can only assume this 10% number is underestimated.
Clearly women desiring MORE SEX with their husbands can’t be a bad thing?
Flibanserin works by changing the balance of various neurotransmitters- dopamine, noradrenaline, and serotonin. The theory is that Flibanserin normalizes or improves these defective brain chemistry pathways which are causing low desire and inhibiting sex drive.
Data from the trenches and the resulting conclusion from the following study (from women who were involved for 24 Months):
In premenopausal women with HSDD, flibanserin 100 mg qhs resulted in significant improvements in the number of SSE and sexual desire (FSFI desire domain score) vs. placebo. Flibanserin was associated with significant reductions in distress associated with sexual dysfunction (FSDS-R total score) and distress associated with low sexual desire (FSDS-R Item 13) vs. placebo. There were no significant safety concerns associated with the use of flibanserin for 24 weeks
The more and more Monica and I read about Flibanserin (from women who’ve actually used it) the more inclined we are to believe it could be an EXTREMELY helpful medication for married couples. More specifically, it should help couples who struggle with intimacy and desire for one another.
Stay tuned for more information on when it will be available, the precise dosage necessary and how you’ll be able to get a prescription.
Be the BEST YOU EVER!
